Target intelligence / Profile preview

Alpha-mannan (Mn) (Mn)

Target
Mn
Molecular classification
Other
01

Overview

Alpha-mannan is a complex, highly branched polysaccharide that serves as a major structural component of the outer cell wall in Candida species, including Candida albicans (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535344/). It consists of an alpha-1,6-linked mannose backbone with side chains of alpha-1,2 and alpha-1,3-linked mannose residues, often modified with phosphodiester-linked beta-1,2-oligomannosides (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659167/). Biologically, alpha-mannan is essential for maintaining cell wall integrity, facilitating adhesion to host tissues, and masking the inner beta-glucan layer from immune detection (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659167/). It acts as a key pathogen-associated molecular pattern (PAMP) recognized by host receptors such as Dectin-2 and the mannose receptor, which are critical for initiating the antifungal immune response (https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.02547/full). In clinical settings, alpha-mannan is a vital biomarker for diagnosing invasive candidiasis through the detection of circulating mannan antigens and corresponding antibodies (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711444/). Furthermore, it is a primary target for experimental vaccines and monoclonal antibodies, such as MAb B6.1, designed to enhance host defense and neutralize fungal virulence factors (https://pubmed.ncbi.nlm.nih.gov/10228070/).

Other names
MannanCandida mannanPhosphomannanN-linked mannanFungal mannanAlpha-linked mannanAlpha-mannan in Candida spp. cell wall
02

Mechanism of action

Drugs and immunotherapies targeting alpha-mannan work by opsonizing fungal cells to promote phagocytosis, neutralizing the immunosuppressive effects of circulating mannan, or enzymatically disrupting the cell wall and biofilm matrix to enhance the efficacy of other antifungal agents.

03

Biological functions

Immune responseOther
04

Disease associations

InfectionInflammation
05

Safety considerations

Immunosuppressive properties of circulating mannan fragmentsSpecies-specific structural variations affecting diagnostic accuracyPotential for false-positive results in diagnostic assays due to cross-reactivity
06

Interacting drugs

MAb B6.1

2 more in the full profile.

07

Biomarkers

Serum mannan antigenAnti-mannan IgG antibodiesAnti-mannan IgM antibodies

Beyond the preview

Go deeper on Alpha-mannan (Mn) (Mn).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-mannan (Mn) (Mn).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call